NCT00683722View on ClinicalTrials.gov

PROCHYMAL™ (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

PHASE2CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

March 20, 2008

Primary Completion Date

March 9, 2009

Study Completion Date

August 24, 2010

Conditions
Pulmonary Disease, Chronic ObstructivePulmonary EmphysemaChronic Bronchitis
Interventions
DRUG

Prochymal™

IV infusion of ex- vivo cultured adult human mesenchymal stem cells.

DRUG

Placebo

IV infusion of excipient of Prochymal™.

Trial Locations (6)

28207

American Health Research, Charlotte

29303

Spartanburg Medical Research, Spartanburg

29615

Upstate Pharmaceutical Research, Greenville

90095

David Geffen School of Medicine at UCLA, Los Angeles

90502

Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center, Torrance

05446

Vermont Lung Center, University of Vermont, Burlington

Sponsors

Lead Sponsor

Mesoblast, Inc.
All Listed Sponsors
lead

Mesoblast, Inc.

INDUSTRY

NCT00683722 - PROCHYMAL™ (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) | Biotech Hunter | Biotech Hunter